Cargando…
Major Decrease in Lung Transplantation for Patients with Cystic Fibrosis in France
Autores principales: | Martin, Clémence, Legeai, Camille, Regard, Lucile, Cantrelle, Christelle, Dorent, Richard, Carlier, Nicolas, Kerbaul, François, Burgel, Pierre-Régis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906480/ https://www.ncbi.nlm.nih.gov/pubmed/34910604 http://dx.doi.org/10.1164/rccm.202109-2121LE |
Ejemplares similares
-
France’s New Lung Transplant Allocation System: Combining Equity With Proximity by Optimizing Geographic Boundaries Through the Supply/Demand Ratio
por: Bayer, Florian, et al.
Publicado: (2022) -
CFTR Modulators in People with Cystic Fibrosis: Real-World Evidence in France
por: Regard, Lucile, et al.
Publicado: (2022) -
Change in Lung Function after Initiation of Elexacaftor–Tezacaftor–Ivacaftor: Do Not Forget Anatomy!
por: Martin, Clémence, et al.
Publicado: (2022) -
Death Rate in Heart Transplant Recipients during the COVID-19 Outbreak in France
por: Legeai, C., et al.
Publicado: (2021) -
Lung Transplant Activity in France during the COVID-19 Outbreak
por: Cantrelle, C., et al.
Publicado: (2021)